The global molecular biology enzymes and kits & reagents market is expected to exceed US$ 12.69 billion by 2022, registering a compound annual growth rate (CAGR) of more than 17.1% during the forecast period. The technological advancements in the life sciences industry, increased research activities in the pharmaceutical and biotechnology sectors, rising incidence of infectious diseases and genetic disorders, and successful completion of the human genome project are expected to drive the market. However, privacy issues related to genetic information and unfavorable reimbursement scenario for genetic testing are hampering the market.
In this report, the global molecular biology enzymes and kits & reagents market is segmented by application, product, end user, and region. On the basis of application, the market is segmented into PCR, sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and others. The market on the basis of product is segmented into kits & reagents and enzymes. On the basis of end user, the market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and others.
The global molecular biology enzymes and kits & reagents market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional molecular biology enzymes and kits & reagents market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
Merck KGaA (Germany), New England Biolabs (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Becton, Dickinson and Company (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), and Takara Bio, Inc. (Japan) are the most active players in the molecular biology enzymes and kits & reagents market.
This report covers the molecular biology enzymes and kits & reagents market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the molecular biology enzymes and kits & reagents market will help customers with the identification of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org